Author: Neel Achary

LatentView Analytics Q2FY25 revenue grew 34.2%YoY and 16.8%QoQ and EBITDA Margin at 21.7%

Chennai, India – November 9, 2024: LatentView Analytics Limited (BSE: 543398, NSE: LATENTVIEW), a global data […]

10th India Affiliate Summit Concludes with Valuable Insights into Performance Marketing

Gurugram, November 8, 2024: The 10th edition of India’s annual premier conference on performance, programmatic and affiliate marketing, the India Affiliate Summit (IAS), organised by the Internet and […]

National Seminar on Pharma Industry’s Fire, Electrical, Security, and Automation Practices Wraps Up

Hyderabad, November 8, 2024- The two-day National Seminar FESA 2024(Fire, Electrical, Security and Automation) for the […]

SurTech and Idea-O-Meter Successfully Organize Academia & Industrial Summit 2024, Fostering Collaboration Among Thought Leaders

Kolkata, 8th November 2024: Dr. Sudhir Chandra Sur Institute of Technology and Sports Complex (SurTech), a […]

Panasonic Energy India Maintains Profit Growth in Q2 FY2024-25

New Delhi, November 8, 2024: Panasonic Energy India Co. Ltd. (PECIN) a part of Panasonic Holdings […]

Eva Aria, Now by Vida Realty, Achieves 50% Sales Milestone in Chembur

Mumbai, 8th November 2024: With the real estate industry projected to grow from USD 518.5 billion […]

IMFA Sees Strong Financial Momentum in Q2 FY25

National, November 8, 2024: Indian Metals & Ferro Alloys Ltd (IMFA; estd 1961), the country’s leading […]

IAMAI Introduces Best Practices Document for Affiliate Marketing in India

Gurugram, November 7, 2024: The Internet and Mobile Association of India (IAMAI) today launched a comprehensive document on the “Best Practices for Affiliate Marketing in India” at […]

Mahindra & Mahindra Q2FY25 First Cut – Robust growth on all counts; SUV demand continues to drive growth

Mahindra & Mahindra Q2FY25 First Cut – Robust growth on all counts; SUV demand continues to […]

Alembic Pharma Sees 12% Increase in Q2FY25 Profit, Touching Rs. 153 Crores

7th November 2024, Mumbai: Alembic Pharmaceuticals Limited reported its consolidated financial results for the second quarter ended 30th September 2024. […]